推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 據(jù)悉，“股東大會(huì)表決結(jié)果顯示，約48431.9萬(wàn)股同意，占出席會(huì)議有效表決股份的97.7572%。”8月2日16時(shí)，在華菱鋼鐵2017年第一次臨時(shí)股東大會(huì)上，公司董事長(zhǎng)曹慧泉宣布了此次股東大會(huì)決議：《關(guān)于公司終止重大資產(chǎn)重組事項(xiàng)的議案》以有效表決股份總數(shù)的三分之二以上同意，獲得高票通過(guò)。
據(jù)原重組方案，華菱鋼鐵擬剝離鋼鐵資產(chǎn)，并置入證券、信托、保險(xiǎn)等金融及節(jié)能發(fā)電資產(chǎn)。后由于擬置入上市公司的金融資產(chǎn)已出現(xiàn)虧損，繼續(xù)實(shí)施原重組方案可能不符合上市公司和投資者利益；擬置出上市公司的鋼鐵資產(chǎn)業(yè)績(jī)已大幅改善，提質(zhì)增效和結(jié)構(gòu)調(diào)整取得積極進(jìn)展；公司與交易對(duì)手方一致決定終止重組，擬置出的鋼鐵資產(chǎn)將繼續(xù)保留在上市公司。公司方面認(rèn)為，這有利于上市公司利用資本市場(chǎng)實(shí)現(xiàn)鋼鐵業(yè)務(wù)轉(zhuǎn)型升級(jí)，更加符合振興實(shí)體經(jīng)濟(jì)的政策導(dǎo)向。
曹慧泉表示，終止重組后，公司將繼續(xù)保持戰(zhàn)略定力，堅(jiān)持“做精做強(qiáng)、區(qū)域領(lǐng)先”的經(jīng)營(yíng)理念，深耕鋼鐵產(chǎn)業(yè)，加快構(gòu)建精益生產(chǎn)、銷研產(chǎn)一體化和營(yíng)銷服務(wù)三大戰(zhàn)略支撐體系，持續(xù)推進(jìn)鋼材產(chǎn)品結(jié)構(gòu)調(diào)整和提質(zhì)增效，提升公司核心競(jìng)爭(zhēng)力。
